Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
05/2008
05/21/2008EP1482924B1 Cathepsin cysteine protease inhibitors
05/21/2008EP1444228B1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/21/2008EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
05/21/2008EP1385508B1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/21/2008EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
05/21/2008CN101184726A 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
05/21/2008CN101182314A Method for preparing 2-(2-butoxy carbonyl amino thiazole-4-group)-2-pentenoic acid ester
05/20/2008US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders
05/20/2008US7375078 for linking drug moieties to ligands; comprises a peptide sequence that is a substrate for an intracellular enzyme, for example a cathepsin, that cleaves the peptide at an amide bond
05/20/2008US7374749 Amino substituted hydroxyphenyl benzophenone derivatives
05/15/2008WO2008057058A1 Oral pharmaceutical compositions
05/15/2008WO2008056808A1 Polyimide, diamine compound and method for producing the same
05/15/2008WO2008055840A1 Thiazole and oxazole-substituted arylamides
05/15/2008WO2008008660B1 Cyclopentane derivatives as antiglaucoma agents
05/15/2008WO2008006969A3 Novel tetracyclic derivatives, process for the preparation thereof and pharmaceutical compositions which contain them
05/15/2008WO2007138112A3 Compounds that interact with ion channels, in particular with ion channels from the kv family
05/15/2008US20080114175 Processes and Intermediates Preparing Cysteine Protease Inhibitors
05/15/2008US20080114167 Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners
05/15/2008US20080114043 Medicinal Composition for Inhalation
05/15/2008US20080114042 Compound
05/15/2008US20080114041 Benzothiazolesulfonamides
05/15/2008US20080113968 Substituted piperazines and diazepanes
05/15/2008CA2668399A1 Thiazole and oxazole-substituted arylamides
05/14/2008EP1921074A1 Thiazole derivative
05/14/2008EP1919885A1 Preparation of 2-amino-thiazole-5-carboxylic-acid derivatives
05/14/2008EP1919861A2 Compounds for treating alzheimer's disease
05/14/2008EP1771425B1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
05/14/2008EP1575922B1 Biphenyl derivatives and their use as fungicides
05/14/2008EP1446375B1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents
05/14/2008CN101180281A Thiazole carboxylic acid anilides
05/14/2008CN100387576C Substituted phenylalkanoic acid derivatives and use thereof
05/13/2008US7371871 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents, sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents, drug abuse withdrawl
05/13/2008US7371860 PNA monomer and precursor
05/13/2008US7371859 Peptide nucleic acid monomers; 1-(4-(benzothiazolyl-, benzoxazolyl-, benzofuranyl-, and benzothiophenyl- sulfonyl)piperidin-3-one-1-ylcarbonylmethyl)adenines; suitable for automatic and parallel synthesis; increased yields
05/13/2008US7371777 Such as 2-(3-{[(4-ethoxybenzoyl)amino]methyl}-4-ethoxybenzyl)-tetrahydro-2-furancarboxylic acid; antihyperglycemia and antihyperlipemia action
05/13/2008US7371770 Acylaminothiazole derivatives and use thereof as β-amyloid inhibitors
05/13/2008US7371767 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5
05/13/2008US7371755 Antiviral agents
05/13/2008US7371751 2,4-dichloro-N-(4-chloro-3-methoxy-phenyl)-N-[4-(pyrrolidine-1-carbonyl)thiazole-2-yl]-benzamide; cannabionic receptor (CB1) antagonist and inverse agonists; side effects reduction; amidation of aminothiazol derivatives with acid chloride and coupling by dehydroxylation with alcohol or amine derivatives
05/13/2008US7371748 Benzothiazole derivatives
05/13/2008US7371747 Cyanoalkylamino derivatives as protease inhibitors
05/08/2008WO2008054749A1 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
05/08/2008WO2008054702A1 Anilinopiperazine derivatives and methods of use thereof
05/08/2008WO2008054701A1 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
05/08/2008WO2008053913A1 Sulfonylurea derivative capable of selectively inhibiting mmp-13
05/08/2008WO2008052804A1 Thiazolhydrazides for treatment of neurodegenerative diseases
05/08/2008WO2008024302A8 Compounds for treating proliferative disorders
05/08/2008WO2008008718B1 Cyclopentane derivatives as antiglaucoma agents
05/08/2008WO2007136607A3 Substituted esters as cannabinoid-1 receptor modulators
05/08/2008US20080108826 Using 4-alkoxytetrahydropyrane derivatives; 1-benzoyl-3-[2-methoxy-5-(tetrahydropyran-4-yl)-phenyl]-thiourea; used in preparation of adenosine receptor ligands
05/08/2008US20080108820 First isolated from the sponge Hemiasterella; for treatment of cancer; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting; methods for synthetic preparation
05/08/2008US20080108809 Benzothiazole derivatives with activity as adenosine receptor ligands
05/08/2008US20080108677 Thioxothiazolidinone Compounds For Use As Pharmaceuticals
05/08/2008US20080108676 Benzothiazolecarboxamides
05/08/2008US20080108675 Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders
05/08/2008US20080108671 Non-systemic control of parasites
05/08/2008US20080108670 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags
05/08/2008US20080108662 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator
05/08/2008US20080108631 Human protein tyrosine phosphatase inhibitors an methods of use
05/08/2008US20080108558 Cross-linked glycopeptide-cephalosporin antibiotics
05/08/2008CA2668255A1 Anilinopiperazine derivatives and methods of use thereof
05/08/2008CA2668210A1 Anilinopiperazine derivatives and methods of use thereof
05/08/2008CA2668209A1 Anilinopiperazine derivatives and methods of use thereof
05/08/2008CA2667249A1 Antidiabetic bicyclic compounds
05/07/2008EP1918286A1 Thiazolhydrazides for treatment of neurodegenerative diseases
05/07/2008EP1918272A1 Pharmaceutically active compounds and methods of use
05/07/2008EP1917240A1 Immunosuppressant compounds and compositions
05/07/2008CN101175737A Pro-drugs of N-thiazol-2yl-benzamide derivatives
05/07/2008CN101172983A Substituted phenylacetic acids
05/07/2008CN101172977A Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
05/07/2008CN101172976A Insect disinfestation component imidazo-triazine compounds
05/06/2008US7368577 Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof
05/06/2008US7368576 Treating breast cancer by dministering a fibroblast activation protein alpha inhibitor is a thiazolidine or a pyrrolidine linked to an amino acid by a peptide bond, e.g., L-threo-isoleucyl pyrrolidine, L-allo-isoleucyl thiazolidine, L-allo-isoleucyl pyrrolydine, L-glutaminyl thiazolidine
05/06/2008US7368572 Anticancer agents
05/06/2008US7368479 Alpha-sulfonylamino-acetonitriles
05/06/2008US7368421 Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
05/06/2008CA2430601C Piperazine derivatives
05/06/2008CA2377803C Phenyl sulfamate derivatives
05/06/2008CA2258949C Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
05/06/2008CA2244979C Proton conductor in liquid form
05/02/2008WO2008050600A1 Therapeutic or preventive agent for intractable disease based on oxidative stress-mediated cell death as molecular background
05/02/2008WO2008050167A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists
05/02/2008WO2008033932A3 Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors
05/02/2008WO2008019030A8 Modified azole compounds as antiinfective agents
05/01/2008US20080103135 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine
04/2008
04/30/2008EP1916234A1 Cyclopropanecarboxylic acid compound
04/30/2008EP1915354A1 Novel benzothiazolone derivatives
04/30/2008EP1915353A2 Isophthalic acid diamides for treating alzheimer disease
04/30/2008EP1915352A1 Compounds for the treatment of alzheimer's disease
04/30/2008EP1915339A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease
04/30/2008EP1915330A1 Fluorination process of anilide derivatives and benzothiazole fluorinate derivatives as in vivo imaging agents
04/30/2008CN101168531A Method for synthesizing rubber accelerator DZ
04/30/2008CN100384834C Epothilone derivatives
04/30/2008CN100384828C Process for preparing 5-[[(3,5-di-tertiary-butyl)-4-hydroxy phenyl] methylene]2-imino-thiazolinone methyl sulfonate
04/30/2008CN100384823C Bicyclic androgen and progesterone receptor modulator compounds and methods
04/29/2008US7365225 Aryl dicarboxamides
04/29/2008US7365209 Nitrogen heterocycle biaryls for osteoporosis and other diseases
04/29/2008US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives
04/29/2008US7365086 Pramipexole acid addition salts
04/29/2008US7365074 Pyridazine, pyrimidine and pyrazine ethyne compounds
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 337